Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis

Kwo, PY; Poordad, F; Asatryan, A; Wang, S; Wyles, DL; Hassanein, T; Felizarta, F; Sulkowski, MS; Gane, E; Maliakkal, B; Overcash, JS; Gordon, SC; Muir, AJ; Aguilar, H; Agarwal, K; Dore, GJ; Lin, CW; Liu, R; Lovell, SS; Ng, TI; Kort, J; Mensa, FJ

Kwo, PY (reprint author), Stanford Univ, Div Gastroenterol & Hepatol, 750 Welch Rd,Suite 210, Palo Alto, CA 94304 USA.

JOURNAL OF HEPATOLOGY, 2017; 67 (2): 263

Abstract

Background & Aims: Hepatitis C virus (HCV) therapy that is highly efficacious, pangenotypic, with a high barrier to resistance and short treatment......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索